Gleevec and Gentamicin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Gentamicin (gentamicin sulfate). Common drug interactions include tinnitus among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Gentamicin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

On Jul, 12, 2026

19 people who take Gleevec and Gentamicin together, and have interactions are studied.

Gleevec and Gentamicin drug interactions.

What are the common drug interactions of Gleevec and Gentamicin, by gender? *:

female:

Tinnitus (a ringing in the ears)
Upper respiratory tract infection
Wheezing (a high-pitched whistling sound made while you breath)
Aplasia (defective development or congenital absence of an organ or tissue)
Blood albumin decreased
Blood bilirubin increased
Chest discomfort
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)
Infusion site pruritus (severe itching at infusion site)

male:

Anaemia (lack of blood)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Aphagia (inability or refusal to swallow)
Corneal oedema (corneal swelling)
Dacryocanaliculitis (1. inflammation of the lacrimal ducts. 2. inflammation of the lacrimal sac and lacrimal canaliculi)
Dehydration (dryness resulting from the removal of water)
Drug resistance (reduction in effectiveness of a drug)
Eye abscess
Eye pruritus (eye itching)
Fluid retention (an abnormal accumulation of fluid in the blood)

What are the common drug interactions of Gleevec and Gentamicin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Aplasia (defective development or congenital absence of an organ or tissue)
Lung infection
Mucosal inflammation (infection of mucous membrane)
Respiratory distress (difficulty in breathing)
Septic shock (shock due to blood infection)
Streptococcal sepsis (whole body inflammation by streptococcal)

30-39:

n/a

40-49:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Aphagia (inability or refusal to swallow)
Corneal oedema (corneal swelling)
Dacryocanaliculitis (1. inflammation of the lacrimal ducts. 2. inflammation of the lacrimal sac and lacrimal canaliculi)
Dehydration (dryness resulting from the removal of water)
Drug resistance (reduction in effectiveness of a drug)
Eye abscess
Eye pruritus (eye itching)
Fluid retention (an abnormal accumulation of fluid in the blood)
Generalised oedema (swelling all over the body)

50-59:

n/a

60+:

Neutropenia (an abnormally low number of neutrophils)
Anaemia (lack of blood)
Coma (state of unconsciousness lasting more than six hours)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Lactic acidosis (low ph in body tissues)
Lung disorder (lung disease)
Nosocomial infection (infection from hospital)
Pleural effusion (water on the lungs)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Quadriplegia (a four limb paralysis)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 26.32%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 26.32%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 10.53%
Neoplasm Recurrence (reoccurrence of tumour): 1 person, 5.26%
Keratitis Fungal (inflammation of the cornea due to fungal organism): 1 person, 5.26%
Fever: 1 person, 5.26%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 5.26%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 1 person, 5.26%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Gentamicin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously